Literature DB >> 25577641

Influenza vaccine and egg allergy: nearing the end of an evidence-based journey.

John M Kelso1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25577641     DOI： 10.1016/j.jaip.2014.08.011

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  6 in total

Review 1.  Vaccine-associated hypersensitivity.

Authors:  Michael M McNeil; Frank DeStefano
Journal:  J Allergy Clin Immunol       Date:  2018-02       Impact factor: 10.793

Review 2.  Safety of influenza vaccination in children with allergic diseases.

Authors:  Hyeon-Jong Yang
Journal:  Clin Exp Vaccine Res       Date:  2015-07-29

3.  Safety of Inactivated Influenza Vaccine in Patients with Egg Allergy in Kurdistan Province, Iran.

Authors:  Sima Tozandehjani; Rasoul Nasiri Kalmarzi; Mazaher Khodabandehloo; Hajar Kashefi
Journal:  Iran J Public Health       Date:  2019-04       Impact factor: 1.429

4.  2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines.

Authors:  F Estelle R Simons; Motohiro Ebisawa; Mario Sanchez-Borges; Bernard Y Thong; Margitta Worm; Luciana Kase Tanno; Richard F Lockey; Yehia M El-Gamal; Simon Ga Brown; Hae-Sim Park; Aziz Sheikh
Journal:  World Allergy Organ J       Date:  2015-10-28       Impact factor: 4.084

5.  Enhancing Seasonal Influenza Surveillance: Topic Analysis of Widely Used Medicinal Drugs Using Twitter Data.

Authors:  Ireneus Kagashe; Zhijun Yan; Imran Suheryani
Journal:  J Med Internet Res       Date:  2017-09-12       Impact factor: 5.428

6.  AstraZeneca ChAdOx1-S COVID-19 vaccine can be safely administered in patients with EDTA allergy.

Authors:  Syed B Ali; Griffith Perkins; Dongjae Ryoo; Maverick Lee; Matthew Tunbridge; Chino Yuson; William Smith; Pravin Hissaria; Thanh-Thao Le
Journal:  Allergy Asthma Clin Immunol       Date:  2022-03-10       Impact factor: 3.406
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.